Tag: biotechnology
-
Hospitals Testing Fast Covid-19 Diagnostic
A New England hospital system is assessing with real patients a point-of-care test for Covid-19 viruses that returns results in about an hour.
-
A.I. Discovery Company Raises $123M in Venture Funds
A company using image analysis and deep learning to discover therapies for diseases often considered difficult to treat is raising $123 million in new venture funds.
-
Trial Testing Rare Disease Drug for Covid-19 Pneumonia
A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospitalized with pneumonia from Covid-19 infections.
-
Breath Analysis Sensor Licensed to Detect Covid-19
Discoveries in a university lab that enable detection of Covid-19 infections from a person’s breath are being licensed for development by a biotechnology company.
-
Giant Hornet Genome Sequenced
The genome of the Asian giant hornet, a species threatening bees and humans, was analyzed, with the data released by the Agricultural Research Service.
-
Grant Funds Placenta Stem Cell Trial Sites for Covid-19
A clinical trial testing stem cells from human placentas as a treatment for Covid-19 infections is expanding to three more sites in California.
-
Start-Up to Engineer T-Cells for Autoimmune Diseases
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.
-
Venture Fund Plans $350M for Biotech Start-Ups
A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology.
-
NIH Begins Covid-19 Antibody Trials
National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe.
-
New Allergy Biotech Launches, Raises $10M
A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round.